Newsroom | 12971 results

VALENCIA, Spain--(BUSINESS WIRE)--Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precis...

MILÁN--(BUSINESS WIRE)--Corcym, una empresa de dispositivos médicos global dedicada a la cirugía cardiaca, anunció hoy que se incluyeron datos positivos a mediano plazo de un subanálisis de su válvula cardíaca aórtica sin sutura Perceval Plus como parte de su ensayo clínico MANTRA en una presentación oral realizada hoy en la reunión anual de la European Association for Cardio-Thoracic Surgery (EACTS). El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducc...

MILAAN--(BUSINESS WIRE)--Corcym, een wereldwijd bedrijf in medische hulpmiddelen dat zich richt op hartchirurgie, heeft vandaag bekendgemaakt dat positieve gegevens op middellange termijn, afkomstig uit een subanalyse van de klinische MANTRA-studie naar de hechtingloze aortaklep Perceval Plus, zijn gepresenteerd tijdens de jaarvergadering van de European Association for Cardio-Thoracic Surgery (EACTS). Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als...

MILANO--(BUSINESS WIRE)--Corcym, lo specialista globale dei dispositivi medici cardiochirurgici, oggi ha annunciato la presentazione dei dati positivi a medio termine di una sottoanalisi della sua valvola aortica senza suture Perceval Plus, parte dello studio clinico MANTRA, nel corso della presentazione orale odierna al congresso annuale della European Association for Cardio-Thoracic Surgery (EACTS). Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione uffi...

MILAN--(BUSINESS WIRE)--Corcym, une société d’envergure mondiale spécialisée dans les dispositifs médicaux destinés à la chirurgie cardiaque, a annoncé aujourd’hui que les résultats positifs à moyen terme issus d’une sous-analyse de sa valve aortique sans suture Perceval Plus, réalisée dans le cadre de son essai clinique MANTRA, avaient fait aujourd’hui l’objet d’une présentation orale à l’occasion du congrès annuel de l’European Association for Cardio-Thoracic Surgery (EACTS). Cette étude, qui...

MAILAND--(BUSINESS WIRE)--Corcym, ein weltweit tätiges Medizintechnikunternehmen mit Schwerpunkt auf Herzchirurgie, gab heute bekannt, dass positive Zwischenergebnisse aus einer Subanalyse seiner nahtlosen Aortenherzklappe „Perceval Plus“ im Rahmen der klinischen Studie „MANTRA“ heute in einem Vortrag auf der Jahrestagung der European Association for Cardio-Thoracic Surgery (EACTS) vorgestellt wurden. Die Studie ist die längste verfügbare Nachbeobachtungsstudie zu Perceval Plus und der FREE-Gew...

MILAN--(BUSINESS WIRE)--Corcym's Perceval Plus sutureless aortic heart valve shows excellent durability, safety and quality of life at up to 7 years at EACTS meeting....

BROOKLYN, New York--(BUSINESS WIRE)--Carrot (formerly Virtual Field), the most widely used VR testing and diagnostic platform in eye care, today announced an agreement to acquire GreenMan Vision, Inc., the company behind InSightVR. The deal will add intraocular lens (IOL) simulation for cataract surgery to the Carrot Platform and expand Carrot from vision diagnostics into vision simulation. “For more than 40 years, patients have dreaded the visual field test,” said Jeremy Barlow, CEO of Carrot....

MAPLE GROVE, Minn.--(BUSINESS WIRE)--Urolution Medical, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OpenFlo® Urinary Catheter, marking a major milestone as the company advances toward clinical evaluation and commercialization. Cleared for urinary tract drainage in adult patients for indwell periods of up to 30 days, OpenFlo® incorporates a patented architecture that re-engineers key mechanical features of the conventional Foley cath...

STUART, Fla.--(BUSINESS WIRE)--Stuart Therapeutics Inc., a late-stage biopharmaceutical company developing a new class of therapeutics designed to treat eye diseases by repairing helical collagen, today announced it has submitted an investigational new drug application amendment to the U.S. Food and Drug Administration to study its lead candidate, ST-100 (vezocolmitide), in corneal wound healing. The planned proof-of-concept study would mark ST-100's first expansion beyond dry eye disease and co...